A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Perphenazine
Delorazepam
The risk or severity of adverse effects can be increased when Ergometrine is combined with Delorazepam.
Perphenazine
Tenamfetamine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Tenamfetamine.
Perphenazine
Difenoxin
The risk or severity of adverse effects can be increased when Ergometrine is combined with Difenoxin.
Perphenazine
Etorphine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Etorphine.
Perphenazine
Dichloralphenazone
The risk or severity of adverse effects can be increased when Ergometrine is combined with Dichloralphenazone.
Perphenazine
Camazepam
The risk or severity of adverse effects can be increased when Ergometrine is combined with Camazepam.
Perphenazine
Dimethyltryptamine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Dimethyltryptamine.
Perphenazine
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of adverse effects can be increased when Ergometrine is combined with 4-Bromo-2,5-dimethoxyamphetamine.
Perphenazine
Barbital
The risk or severity of adverse effects can be increased when Ergometrine is combined with Barbital.
Perphenazine
Ethylmorphine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Ethylmorphine.
Perphenazine
Fencamfamin
The risk or severity of adverse effects can be increased when Ergometrine is combined with Fencamfamin.
Perphenazine
Midomafetamine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Midomafetamine.
Perphenazine
Diamorphine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Diamorphine.
Perphenazine
Dihydroetorphine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Dihydroetorphine.
Perphenazine
Bufotenine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Bufotenine.
Perphenazine
MMDA
The risk or severity of adverse effects can be increased when Ergometrine is combined with MMDA.
Perphenazine
gamma-Hydroxybutyric acid
The risk or severity of adverse effects can be increased when Ergometrine is combined with gamma-Hydroxybutyric acid.
Perphenazine
Glutethimide
The risk or severity of adverse effects can be increased when Ergometrine is combined with Glutethimide.
Perphenazine
Methadyl acetate
The risk or severity of adverse effects can be increased when Ergometrine is combined with Methadyl acetate.
Perphenazine
Yohimbine
The risk or severity of adverse effects can be increased when Ergometrine is combined with Yohimbine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3